Why Agency M&A Slowed in 2026: What IMOs Must Do Now to Protect Their Valuation

Agency M&A slowed in 2026 because buyers turned selective as financing costs stayed high, organic growth cooled, and the market shifted from broad consolidation to quality-focused buying. OPTIS Partners counted only 292 H1 2026 deals, a slowdown MarshBerry ties to a hawkish rate outlook and softer premium growth. For an IMO, the practical question is no longer whether the market is soft, it is whether your downline reads as a platform buyers will still pay up for.

Why did agency M&A slow down in 2026?

Agency M&A slowed in 2026 because buyers turned selective as financing costs stayed high, organic growth cooled, and the market shifted from broad consolidation to quality-focused buying. OPTIS Partners counted only 292 H1 2026 deals, a slowdown MarshBerry ties to a hawkish rate outlook and softer premium growth.

For an IMO, this is not a story about fewer buyers wanting distribution. It is a story about fewer buyers wanting distribution on the old terms. PwC's midyear 2026 outlook is blunt about the mechanics: deal drivers remain intact, but headline value has moderated and transaction volume has declined, with a private-market pricing reset likely if public broker multiples stay depressed. That reset does not fall evenly. An override book built on a wide, active, well-documented downline still draws bids. An override book built on scale alone, with agent activity nobody can verify, gets discounted before diligence even starts.

What are the key statistics behind the 2026 slowdown?

The 2026 slowdown is documented in hard numbers: Q1 2026 volume fell to 148 deals, the slowest start since 2016, and Q2 2026 dropped further to 138 transactions, down 25% year over year, per PwC. The trailing twelve months through June 2026 totaled 646 deals, the lowest since Q1 2019.

Risk & Insurance also notes Q1 2026 marked the tenth consecutive quarter below the long-term trend line, which tells an IMO this is not a one-quarter blip, it is a multi-year repricing of how buyers view distribution. Pexara's data adds context: full-year 2025 already closed at 695 deals, down 12% from 2024, so the pullback predates 2026 and has now compounded.

Period	Deal count (number)	Change vs. prior comparable period
H1 2026	292	Down 15% from 342 in H1 2025
Q1 2026	148	Down 6% year over year
Q2 2026	138	Down 25% year over year
TTM through June 2026	646	Down 17% year over year
FY 2025	695	Down 12% from 2024

How is the slowdown affecting agency and IMO valuations?

Valuations have not fallen as sharply as deal volume, but the range has widened between platform-quality agencies and everyone else. Average EBITDA multiples for deals above $1 million in EBITDA held near 11.8x in H1 2025, versus 11.9x in 2024 and a 9.4x trough in 2020, per Risk & Insurance.

At the smaller end, Insurance Journal reports revenue multiples for small agencies still ranging from 1.1x to 2.2x annual premium. For an IMO evaluating its own hierarchy or a downline agency it might absorb, that spread matters: a book of contracts with strong retention and clean data sits at the top of the range, while a book with unverifiable production sits at the bottom regardless of size. The market is still transacting, it is simply pricing quality far more aggressively than it priced scale two years ago.

How can IMOs prove organic growth quality to buyers?

IMOs prove organic growth quality by separating true new-business production, agents actively writing and retaining policy, from growth driven by rate increases, exposure change, or bolt-on acquisitions. Buyers reward hierarchies that can show override revenue rising because more contracted agents are producing, not because premiums rose.

This means tracking agent activation cohorts, not just aggregate hierarchy premium. An IMO that can show, cohort by cohort, how many newly contracted agents wrote a first policy within 30 days, and how many were still active at 12 months, is showing a buyer a repeatable recruiting-and-activation engine rather than a lucky year. A shared CRM across the downline, the kind Kadence provides as part of an AI system built to grow life insurance distribution front to back office, gives every agency in the hierarchy the same pipeline structure, so an IMO can pull cohort-level activation and retention data without chasing spreadsheets from a hundred separate agencies.

Why does a modern tech stack matter for IMO valuation?

A modern, documented tech stack raises IMO valuation because it lowers a buyer's integration risk across a large downline. Agencies with a documented, scalable technology stack command 15 to 20% higher valuation multiples from strategic buyers, and proven infrastructure alone can add 0.5x to 1.0x to EBITDA multiples, according to Kadence's tech maturity multiple analysis.

Most of the industry has not closed this gap. That same analysis puts the CRM adoption gap among insurance agencies at 24%, the data and analytics adoption gap at 19%, and AI-assisted follow-up adoption under 10%. For an IMO, that gap is a competitive opening: a hierarchy that hands every downline agency a working CRM, instant lead routing, and automated follow-up is not just improving production, it is closing the exact gap buyers now discount for. Read the full tech maturity multiple audit for the underlying scoring criteria.

How can IMOs reduce integration friction before a sale?

IMOs reduce integration friction by closing CRM adoption gaps first, then automating follow-up, then layering in analytics, the sequence research shows maximizes exit multiples. Unused software licenses across a downline create technical debt, so tools that sit idle should be shut off or paired with documented SOPs before a sale.

The recommended sequence, in order:

1. Close CRM adoption gaps across every downline agency so pipeline, retention, and account ownership data is consistent hierarchy-wide.
2. Automate follow-up on inbound and aged leads so agent-level response speed is uniform, not dependent on any one producer's habits.
3. Build the analytics and reporting layer last, once the first two steps guarantee the underlying data is clean.

Buyers also want a documentation package: architecture diagrams, deployment procedures, and incident response playbooks for whatever platform the downline runs on, plus proof that best-of-breed tools are connected through APIs rather than bolted together as a disconnected single-vendor stack. Proprietary, client-facing reporting tools that create switching costs can add another 10 to 20% to valuation, per Kadence's tech maturity multiple analysis, because they make the hierarchy harder to unwind after close.

Who are the dominant buyers in 2026 and what do they want?

Private-equity-backed and hybrid buyers dominate 2026, accounting for 76% of H1 2026 acquisitions and 80% of Q2 2026 deals, per Insurasales and Insurance Business Magazine. Only 68 unique buyers were active in H1 2026, 37 private-equity-backed and 21 privately held, so IMOs are courting a narrower, more disciplined buyer pool.

MarshBerry's commentary, cited in Insurance Journal, describes buyers as more selective while still "favoring brokerages with clear growth strategies." That is a direct signal for IMOs: a private-equity buyer evaluating a hierarchy wants a repeatable playbook it can run across your downline after close, agent recruiting funnels that keep producing, activation systems that keep contracts from going dormant, and retention systems that keep agents from rolling to a competing IMO. A narrower buyer pool with a sharper thesis rewards hierarchies that can hand over that playbook, not just a book of contracts.

How does compliance affect M&A outcomes for IMOs?

Compliance weaknesses slow deals even when headline multiples hold, because buyers shift focus from speed to cleanup requirements in a choosier market. An IMO whose downline lacks consistent proof of compliant outreach practices, opt-out handling, or licensing documentation across agents faces added diligence time and can see valuation discounted before close.

This is operational guidance, not legal advice, and an IMO should confirm current TCPA and National DNC obligations with counsel before changing outreach practice. What is squarely operational is standardizing how consent and opt-outs are logged across every downline agency and making multi-state licensing and routing verifiable at the hierarchy level rather than agency by agency. Kadence's Voice AI logs call consent status and opt-out requests automatically for every call it places on a downline agent's behalf, which gives an IMO one uniform compliance record instead of a hundred separate ones a buyer has to reconstruct by hand.

What should IMOs track to prove normalized EBITDA?

IMOs prove normalized EBITDA by producing trailing-twelve-month reports on lead-to-bind conversion, cost per acquisition, and retention rate, the exact figures buyers audit during diligence. Reporting must also separate new-business growth from rate, exposure, and acquisition effects so a buyer can see how much of override revenue is truly organic.

An IMO should be able to hand a buyer, on request, a report that breaks override revenue into new business from newly activated agents, retained renewal premium, and any growth from rate or exposure change. This is where speed-to-lead and pipeline discipline at the agent level compound into hierarchy-level numbers a buyer can trust, since clean agent-level data is what makes hierarchy-level normalization credible instead of asserted.

How can IMOs cut agent and producer concentration risk?

IMOs cut concentration risk by widening the base of active, producing agents so no single agent or small cluster drives a disproportionate share of override revenue. Buyers scrutinize producer concentration alongside retention and client mix, and a downline where the top 5 agents generate the majority of premium reads as fragile.

Cutting that risk means treating recruiting and activation as a continuous funnel rather than a periodic push. An IMO that can show a steady cadence of newly contracted agents reaching first-sale within a defined window, and staying active past the 12-month mark, is showing a buyer that override revenue does not depend on a handful of top producers who could leave for a competing IMO. Pushing key carrier relationships and downline account knowledge into a documented leadership bench, rather than concentrating it in one or two people, does the same work at the management layer.

What warning signs mean buyers will discount your downline?

Buyers discount a downline that cannot document agent activation, relies on unverified aggregate premium, or concentrates override revenue in a handful of producers. Kadence's tech maturity multiple analysis ties a 24% CRM adoption gap and under-10% AI-assisted follow-up adoption directly to the lower strategic-buyer multiples seen industry-wide.

Most of these signals are visible to an IMO long before a buyer ever sees them, which means they are fixable before diligence starts rather than explained away during it.

Warning sign	Why it lowers the multiple	Fix before engaging a buyer
No agent-level activation cohort data	Buyer cannot verify organic growth is real	Track first-sale timing and 12-month activity by cohort
CRM adoption below hierarchy-wide standard	Integration risk rises during diligence	Roll out one CRM to every downline agency
Override revenue concentrated in top 5 agents	Reads as fragile, dependent on a few people	Widen the active producer base through recruiting funnels
Inconsistent licensing records across states	Adds diligence time and legal review cost	Centralize multi-state licensing and routing at hierarchy level

An IMO that closes even two of these four gaps before a first buyer conversation changes the tone of the negotiation, because the diligence team spends its time confirming numbers instead of hunting for them.

How should IMOs prepare for a bifurcated valuation market?

IMOs should prepare for a bifurcated market by positioning as a platform-quality hierarchy rather than a scale-only roll-up target, since buyers in 2026 pay up for durable growth and clean integration, not headcount. PwC's midyear outlook warns that if public broker multiples stay depressed, a private-market pricing reset is likely.

Segment	Typical multiple range	What drives it
Small agency, revenue basis	1.1x to 2.2x annual premium	Book size, limited documentation
Strong agency, commission basis	2.5x to 3.2x annual commissions	Retention, producer depth, clean data
Platform-scale, EBITDA basis	Roughly 9.4x to 11.9x EBITDA (2020 to 2024)	Repeatable integration, organic growth quality

An IMO sitting on a mixed downline, some agencies platform-ready, others still manual, should not wait for the whole hierarchy to catch up before engaging buyers. It should be able to show, agency by agency, which parts of the book already meet the higher bar and which are being actively upgraded.

How can an IMO start protecting its valuation now?

An IMO starts protecting its valuation by auditing downline tech adoption, documenting agent-level production and retention data, and closing the CRM and follow-up gaps that create integration risk before a buyer ever asks. Kadence gives IMOs a shared front and back office across the entire downline; book a demo to see how it works.

That means giving every contracted agency the same CRM, the same Voice AI answering and routing every lead in under 10 seconds so no downline agent loses a prospect to slow response, and the same commission tracking with persistency and production visibility rolling up to the hierarchy level. A downline that runs on one system is easier to activate, easier to retain, and, when the market gets choosy again, far easier to defend in front of a buyer.

Sources

• Insurance: US Deals 2026 midyear outlook
• Insurance Agency M&A Slows as Buyers Become More Selective
• Insurance Mergers and Acquisitions Decline in First Half of 2026
• Insurance Distribution M&A Activity Hits Decade Low as Three-Year Slide Shows Signs of Bottoming Out
• The Roll-Up Slowdown: What a Seven-Year Low in Agency M&A Means for Independent Markets
• The new M&A reality: Insurance choosing scale over value in 2026
• Insurance M&A Pace Down 15% in First Half 2026: OPTIS
• Industry Trends to Exploit for 2026: Part One